In situ carcinoma
MONDO:0004647A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.
Also known as: CIS, carcinoma in situ, carcinoma, in situ, malignant, epithelial tumor, in situ, malignant, intraepithelial carcinoma, non-invasive carcinoma, stage 0 disease
3066 clinical trials for this condition and its sub-types, 25 tagged with In situ carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of In situ carcinoma
-
Breast carcinoma in situ 76 trials · 204 incl. sub-types
4 sub-types
- Ductal breast carcinoma in situ 152 trials Sub-types →
- Lobular neoplasia 4 trials · 30 incl. sub-types Sub-types →
- Ductal breast carcinoma in situ and lobular carcinoma in situ 1 trial
- Breast apocrine carcinoma in situ 0 trials
-
Adenocarcinoma in situ 10 trials · 170 incl. sub-types
3 sub-types
- Ductal breast carcinoma in situ 152 trials Sub-types →
- Lobular breast carcinoma in situ 27 trials
- Lung adenocarcinoma in situ 1 trial
-
Bladder carcinoma in situ 30 trials
-
Intestine carcinoma in situ 0 trials · 16 incl. sub-types
2 sub-types
- Rectum carcinoma in situ 1 trial · 13 incl. sub-types Sub-types →
- Colon carcinoma in situ 3 trials Sub-types →
-
Uterus carcinoma in situ 0 trials · 16 incl. sub-types
2 sub-types
- Uterine cervix carcinoma in situ 15 trials
- Endometrium carcinoma in situ 1 trial
-
Esophagus carcinoma in situ 13 trials
-
Squamous carcinoma in situ 5 trials · 10 incl. sub-types
3 sub-types
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
- Penis carcinoma in situ 1 trial
- Trachea carcinoma in situ 0 trials
-
Skin carcinoma in situ 3 trials · 9 incl. sub-types
1 sub-type
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
-
Oral cavity carcinoma in situ 5 trials
1 sub-type
- Lip carcinoma in situ 0 trials
-
Stomach carcinoma in situ 4 trials
3 sub-types
- Carcinoma in situ of fundus of stomach 0 trials
- Carcinoma in situ of gastric body 0 trials
- Carcinoma in situ of gastric cardia 0 trials
-
Lung carcinoma in situ 2 trials · 3 incl. sub-types
2 sub-types
- Lung adenocarcinoma in situ 1 trial
- Bronchus carcinoma in situ 0 trials
-
Pharynx carcinoma in situ 0 trials · 2 incl. sub-types
3 sub-types
-
Larynx carcinoma in situ 1 trial
1 sub-type
- Carcinoma in situ of epiglottis 0 trials
-
Carcinoma in situ of ureter 0 trials
-
Carcinoma in situ of urethra 0 trials
-
Eye carcinoma in situ 0 trials
-
Gall bladder carcinoma in situ 0 trials
-
Kidney carcinoma in situ 0 trials
1 sub-type
- Carcinoma in situ of renal pelvis 0 trials
-
Liver carcinoma in situ 0 trials
1 sub-type
- Bile duct carcinoma in situ 0 trials Sub-types →
-
Nasal cavity carcinoma in situ 0 trials
Most studied deeper sub-types
-
New hope for tough bladder cancer: immune drug plus chemo combo enters trial
Disease control Not yet recruitingThis study tests whether adding chemotherapy drugs (gemcitabine and mitomycin C) directly into the bladder alongside an immune-boosting drug (toripalimab) works better than toripalimab alone for people with a high-risk bladder cancer that did not respond to standard BCG therapy. …
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New light treatment could fight oral cancer without surgery
Disease control Not yet recruitingThis study tests a low-cost approach to treat pre-cancerous and cancerous mouth lesions using a drug (5-ALA) that makes abnormal cells sensitive to light, followed by laser light delivered through a handheld device. The goal is to destroy these lesions without surgery. The trial …
Phase 2 • Sponsor: University of Massachusetts, Boston • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Earlier drain removal after breast reconstruction may boost recovery and satisfaction
Symptom relief Not yet recruitingThis study compares removing drainage tubes earlier versus later after a specific type of nipple-sparing mastectomy with immediate breast implant reconstruction. About 379 women aged 18–70 with breast cancer or those having preventive mastectomy will take part. The goal is to see…
Sponsor: Du Zhenggui • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC